NCT03855657 Biobank - Investigating the Gut Microbiota, Genetics, Epigenetics and Metabolites
| NCT ID | NCT03855657 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Chinese University of Hong Kong |
| Condition | Inflammatory Bowel Diseases |
| Study Type | OBSERVATIONAL |
| Enrollment | 6,000 participants |
| Start Date | 2014-03 |
| Primary Completion | 2034-02 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 6,000 participants in total. It began in 2014-03 with a primary completion date of 2034-02.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Inflammatory bowel disease (IBD) affects 1 in 500 to 1,000 people in the West. Previously a disease predominantly of the West, there is now a marked increase in the incidence of ulcerative colitis (UC) and Crohn's disease (CD) in Asia, with an estimated prevalence of 1 in 3,000 and 1 in 10,000 respectively\[1\]. The rapid increase of IBD in Asian raising concern of investigators. Therefore setting up a large scale biobank with comprehensive clinical data is require.
Eligibility Criteria
Inclusion Criteria: * Patient ≥18 with a diagnosis of Crohn's disease or ulcerative colitis * Informed Consent obtained Exclusion Criteria: * Known current infection with an enteric pathogen * Previously been diagnosed with IBD (Control) * Have a first of second degree relative with IBD (Control)
Contact & Investigator
Siew Chien Ng, PhD
PRINCIPAL INVESTIGATOR
Chinese University of Hong Kong
Frequently Asked Questions
Who can join the NCT03855657 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Inflammatory Bowel Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03855657 currently recruiting?
Yes, NCT03855657 is actively recruiting participants. Contact the research team at siewchienng@cuhk.edu.hk for enrollment information.
Where is the NCT03855657 trial being conducted?
This trial is being conducted at Hong Kong, Hong Kong.
Who is sponsoring the NCT03855657 clinical trial?
NCT03855657 is sponsored by Chinese University of Hong Kong. The principal investigator is Siew Chien Ng, PhD at Chinese University of Hong Kong. The trial plans to enroll 6,000 participants.